GGrantIndex
← Leaderboards

Patrice Delafontaine Delafontaine

University Of Alabama At Birmingham

$22,562,874
Attributed
$32,338,055
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $10.5M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,338,055 · 3

By mechanism

UM1$19,550,362 · 1
R01$12,787,693 · 2

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Insight

Research focus

InsightInsulin-Like Growth Factor IInsulin-Like-Growth Factor I ReceptorApoptosisSignal TransductionMediatingCellsAtherosclerosisAutocrineInfusion ProceduresMorbidity - Disease RateAreaArterial Fatty StreakCardiovascular DiseasesRodentMacrophageNovel TherapeuticsPreventionInsulinMortality Vital StatisticsApolipoprotein EBiologyGrantOverexpression

Grant awards (33)

CTSA UM1 at the University of Alabama at Birmingham$9,681,310
UM1 · FY2025 · TR
Insulin-Like Growth Factor-1 and Atherosclerosis$678,728
R01 · FY2025 · HL · contact PI
CTSA UM1 at the University of Alabama at Birmingham$9,869,052
UM1 · FY2024 · TR
Insulin-Like Growth Factor-1 and Atherosclerosis$665,154
R01 · FY2024 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$691,978
R01 · FY2023 · HL · contact PI
IGF-1 and Alzheimer's Disease$380,000
R01 · FY2020 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$350,560
R01 · FY2020 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$582,527
R01 · FY2019 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$657,781
R01 · FY2018 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$657,781
R01 · FY2017 · HL · contact PI
ANGIOTENSIN II, IGF-1 AND SKELETAL MUSCLE ATROPHY$377,993
R01 · FY2015 · HL · contact PI
Insulin-like Growth Factor-1 and Atherosclerosis$364,397
R01 · FY2015 · HL · contact PI
Insulin-like Growth Factor-1 and Atherosclerosis$368,725
R01 · FY2014 · HL · contact PI
ANGIOTENSIN II, IGF-1 AND SKELETAL MUSCLE ATROPHY$361,200
R01 · FY2014 · HL · contact PI
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy$7,525
R01 · FY2014 · HL · contact PI
Insulin-like Growth Factor-1 and Atherosclerosis$358,190
R01 · FY2013 · HL · contact PI
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy$358,190
R01 · FY2013 · HL · contact PI
Insulin-like Growth Factor-1 and Atherosclerosis$376,250
R01 · FY2012 · HL · contact PI
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy$376,250
R01 · FY2012 · HL · contact PI
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy$371,250
R01 · FY2011 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$372,500
R01 · FY2010 · HL · contact PI
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy$371,250
R01 · FY2010 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$372,500
R01 · FY2009 · HL · contact PI
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy$371,250
R01 · FY2009 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$372,500
R01 · FY2008 · HL · contact PI
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy$371,250
R01 · FY2008 · HL · contact PI
Insulin-Like Growth Factor-1 and Atherosclerosis$372,500
R01 · FY2007 · HL · contact PI
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy$371,250
R01 · FY2007 · HL · contact PI
Insulin-Like Growth Factor-1and Atherosclerosis$363,746
R01 · FY2006 · HL · contact PI
Insulin-Like Growth Factor-1and Atherosclerosis$362,526
R01 · FY2006 · HL · contact PI
Insulin-Like Growth Factor-1and Atherosclerosis$371,250
R01 · FY2005 · HL
Insulin-Like Growth Factor-1and Atherosclerosis$371,250
R01 · FY2004 · HL
Insulin-Like Growth Factor-1 and Atherosclerosis$359,442
R01 · FY2003 · HL